FDA Inspection 1058877 — David E. Griffith, MD

David E. Griffith, MD — FEI 3014427480

The FDA completed an inspection of David E. Griffith, MD on Jun 12, 2018 in Tyler, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 12, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tyler, TX (United States)

Additional Details

Clinical Investigator (CI)